| Product Code: ETC8858386 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Poland CIS insulin market, the import trend exhibited a notable growth rate of 19.81% from 2023 to 2024, with a compound annual growth rate (CAGR) of 41.23% from 2020 to 2024. This acceleration in import momentum could be attributed to evolving healthcare policies and increased demand for advanced insulin products within the region.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland CIS Insulin Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland CIS Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Poland CIS Insulin Market - Industry Life Cycle |
3.4 Poland CIS Insulin Market - Porter's Five Forces |
3.5 Poland CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Poland CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Poland CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 Poland CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Poland and CIS countries |
4.2.2 Rising awareness about the importance of diabetes management and insulin therapy |
4.2.3 Technological advancements in insulin delivery systems |
4.2.4 Growing investments in healthcare infrastructure in the region |
4.3 Market Restraints |
4.3.1 High cost associated with insulin therapy |
4.3.2 Stringent regulatory requirements for insulin products |
4.3.3 Limited access to healthcare services in certain regions |
4.3.4 Challenges in achieving optimal glycemic control in diabetic patients |
5 Poland CIS Insulin Market Trends |
6 Poland CIS Insulin Market, By Types |
6.1 Poland CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Poland CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Poland CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.1.4 Poland CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.2 Poland CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Poland CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F |
6.2.3 Poland CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F |
6.2.4 Poland CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F |
6.2.5 Poland CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.6 Poland CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F |
6.3 Poland CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 Poland CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F |
6.3.3 Poland CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F |
7 Poland CIS Insulin Market Import-Export Trade Statistics |
7.1 Poland CIS Insulin Market Export to Major Countries |
7.2 Poland CIS Insulin Market Imports from Major Countries |
8 Poland CIS Insulin Market Key Performance Indicators |
8.1 Average HbA1c levels in diabetic patients |
8.2 Adoption rate of advanced insulin delivery devices |
8.3 Number of diabetes education programs conducted in the region |
8.4 Percentage of diabetic population receiving regular screenings for complications |
8.5 Rate of hospital admissions due to diabetes-related complications |
9 Poland CIS Insulin Market - Opportunity Assessment |
9.1 Poland CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Poland CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Poland CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 Poland CIS Insulin Market - Competitive Landscape |
10.1 Poland CIS Insulin Market Revenue Share, By Companies, 2024 |
10.2 Poland CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |